TITLE

Dual effects of sodium butyrate on hepatocellular carcinoma cells

AUTHOR(S)
Jiang, Wenjun; Guo, Qiya; Wu, Jun; Guo, Bin; Wang, Yingming; Zhao, Shenan; Lou, Huiling; Yu, Xin; Mei, Xinyu; Wu, Chaoqun; Qiao, Shouyi; Wu, Yanhua
PUB. DATE
May 2012
SOURCE
Molecular Biology Reports;May2012, Vol. 39 Issue 5, p6235
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Sodium butyrate (NaBu), a histone deacetylase inhibitor, has been shown to inhibit cell growth, induce cell differentiation and apoptosis in multiple cell lines. In present study, we revealed the dual effects of NaBu in regulating hepatocellular carcinoma (HCC) cells. In two different HCC cell lines, SK-Hep1 and SMMC-7721, low concentrations of NaBu induced a significant increase in cell growth ratio and S-phase cell percentage, accompanied by a reduced p21 Cip1 expression at both mRNA and protein levels, while dissimilarly, high concentrations of NaBu inhibited cell growth and induced G1 arrest through up-regulation of p21 Cip1 and p27 Kip1 protein expression. The reduction of p45 Skp2 expression further indicated that the ubiquitin-mediated protein degradation might play a role in NaBu-induced up-regulation of p21 Cip1 and p27 Kip1. Moreover, the high concentration of NaBu was also able to trigger HCC cell apoptosis. Taken together, these results demonstrate the distinct effects of NaBu at different dosages. This finding may contribute to develop more effective tumor therapeutic protocols of NaBu in HCC.
ACCESSION #
73763102

 

Related Articles

  • The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme. Burzynski, Stanislaw R.; Patil, Sonali S. // Journal of Cancer Therapy;Sep2014, Vol. 5 Issue 10, p929 

    Antineoplastons are peptide and amino acid derivatives that occur naturally in the human body. They inhibit the growth of neoplastic cells without growth inhibition of normal cells. Phenylacetylglutaminate (PG) is an active ingredient of antineoplastons A10 and AS2-1 (ANP) and is also a...

  • Different effect of natural inhibitor of histone deacetylases on cancer and normal prostate cells. Paskova, Lenka; Smesny Trtkova, Katerina; Fialova, Barbora; Kolar, Zdenek // Biomedical Papers of the Medical Faculty of Palacky University i;Dec2012, Vol. 156 Issue Supp 3, pS120 

    Sodium butyrate (NaB), as a natural inhibitor of histone deacetylases (HDACI), is a non-toxic agent, with an ability to modify histone acetylation and affect the expression large number of genes, including also coregulators of androgen receptor (AR). Coregulators, including coactivators and...

  • Expression and prognostic value of Ars2 in hepatocellular carcinoma. He, Qian; Huang, Yongde; Cai, Lei; Zhang, Shaobo; Zhang, Chenghua // International Journal of Clinical Oncology;Oct2014, Vol. 19 Issue 5, p880 

    Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Arsenic resistance protein 2 (Asr2) was reported to be important for microRNA (miR) biogenesis, and its depletion could reduce the levels of several miRs, including miR-21, which is over-expressed in...

  • Cancer: Liver cancer lifeline found.  // Nature;3/24/2011, Vol. 471 Issue 7339, p412 

    The article offers information on a research regarding the genomes of 89 liver tumours and 12 liver-cancer cells, which shows that cancer cells depend on the overexpression of such genes for their survival and growths.

  • Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue–influence of a modulated host stroma on the prognosis of HCC. Simon, Frank; Bockhorn, Maximilian; Praha, Christian; Baba, Hideo A.; Broelsch, Christoph E.; Frilling, Andrea; Weber, Frank // Langenbeck's Archives of Surgery;Apr2010, Vol. 395 Issue 4, p395 

    The aim of this study was to elucidate the role of HIF1A expression in hepatocellular carcinoma (HCC) and the corresponding non-malignant liver tissue and to correlate it with the clinical outcome of HCC patients after curative liver resection. HIF1A expression was determined by quantitative...

  • Prolactin Promotes Hepatocellular Carcinoma through Janus Kinase 2. Yeh, Yao-Tsung; Lee, King-Teh; Tsai, Chia-Jung; Chen, Yu-Jie; Wang, Shen-Nien // World Journal of Surgery;May2012, Vol. 36 Issue 5, p1128 

    Background: Hepatocelluar carcinoma (HCC) is one human cancer with obvious gender disparity. This study investigated the association of aberrant prolactin levels with HCC risk and the potential impacts on HCC of the prolactin receptor (PRLR)/Janus kinase 2 (JAK2) signaling. Methods: Serum...

  • SP1 suppresses phorbol 12-myristate 13-acetate induced up-regulation of human regucalcin expression in liver cancer cells. Xu, Hong; Ni, Peihua; Chen, Changqiang; Yao, Yuting; Zhao, Xiaoping; Qian, Guanxiang; Fan, Xianqun; Ge, Shengfang // Molecular & Cellular Biochemistry;Sep2011, Vol. 355 Issue 1/2, p9 

    There is a growing evidence that regucalcin (RGN) plays a multifunctional role in liver cancer cells. Previous reports showed that the presence of phorbol 12-myristate 13-acetate (PMA) caused a significant increase in RGN mRNA expression and promoter activity in rat hepatoma cells. In this...

  • 944. Inhibiting Survivin Expression Enhances Trail-Induced Apoptosis in Human Hepatocellular Carcinoma. Song-Qing He; Ming-Guang Gong; Zhi-Yong Huang; Chang-Hai Li; Wan-Guang Zhang; Jian Wu; Xiao-Ping Chen // Molecular Therapy;Jun2006, Vol. 13, pS364 

    Background: The fact that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces profound apoptosis in a wide range of tumor cell lines but lacks cytotoxicity to mosnormal cells raises hope that TRAIL might become a novel potential anticancer agent. Our previous studies shown...

  • Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU. BO TANG; ZHIGAO HU; YANG LI; SHENGGUANG YUAN; ZHENRAN WANG; SHUIPING YU; SONGQING HE // Molecular Medicine Reports;2016, Vol. 13 Issue 1, p59 

    δ opioid receptor (DOR) was the first opioid receptor of the G protein-coupled receptor family to be cloned. Our previous studies demonstrated that DOR is involved in regulating the development and progression of human hepatocellular carcinoma (HCC), and is involved in the regulation of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics